Opinion Author: Lee S. Cohen, MD Publish date: August 28, 2020
The most common reasons for consultation on our service continue to be the appropriate, safest use of antidepressants and mood stabilizers during p...
Opinion Author: Lee S. Cohen, MD Publish date: April 29, 2020
Maternal psychiatric well-being during pregnancy is a strong predictor of obstetrical and neonatal outcomes, and ...
Opinion Author: Lee S. Cohen, MD Publish date: January 30, 2020
Postpartum psychosis is relatively rare, with an incidence of 1 in 1,000 births, but it is one of the most serious complications of modern obstetri...
Opinion Author: Lee S. Cohen, MD Publish date: September 10, 2019
Where does brexanolone fit into the algorithm for treating women who suffer from postpartum depression?
Opinion Author: Lee S. Cohen, MD Publish date: May 1, 2019
Sustaining euthymia is perhaps the single most critical principle in managing bipolar women during pregnancy and the postpartum period.
Opinion Author: Lee S. Cohen, MD Publish date: January 30, 2019
Women at greatest risk include those with a history of PPD, bipolar disorder, or postpartum psychosis.
Opinion Author: Lee S. Cohen, MD Publish date: August 23, 2018
Managing bipolar disorder during pregnancy requires weighing the reproductive safety of psychiatric medicines and...
Opinion Author: Lee S. Cohen, MD Publish date: April 23, 2018
There is a continuum of risk when it comes to the effects of depression during pregnancy.
Opinion Author: Lee S. Cohen, MD Publish date: November 22, 2017
The MGH Perinatal Depression Scale (MGHPDS) is an app that screens for postpartum depression during and after pregnancy.
Opinion Author: Lee S. Cohen, MD Publish date: July 3, 2017
Here are 10 clinical scenarios in which practice diverges from the best clinical evidence.
News Author: Lee S. Cohen, MD Publish date: March 3, 2017
Depression screening during and after pregnancy is recommended, but does it result in more women getting treatment?
Article Author: Lee S. Cohen, MD Publish date: November 1, 2016
In this article, our four expert columnists share their experiences trying to find and interpret critical pregnancy data, as well as how they weigh...
News Author: Lee S. Cohen, MD Publish date: August 23, 2016
Dr. Lee S. Cohen discusses SAGE-547, a novel experimental therapy for severe postpartum depression.
News Author: Lee S. Cohen, MD Publish date: March 23, 2016
The move toward perinatal depression screening is welcome and simply commonsense, but it is concerning that there has been so little systematic stu...
News Author: Lee S. Cohen, MD Publish date: November 11, 2015
While women who take antidepressants during pregnancy may worry about the risk of malformations, they also are concerned about how fetal exposure to S...
